Qin A - Search Results

1

A Pilot Study of Atezolizumab Plus Hypofractionated Image Guided Radiation Therapy for the Treatment of Advanced Non-Small Cell Lung Cancer.

Qin A, Rengan R, Lee S, Santana-Davila R, Goulart BHL, Martins R, Baik C, Kalemkerian GP, Hassan KA, Schneider BJ, Hayman JA, Jolly S, Hearn J, Lawrence TS, Towlerton AMH, Tewari M, Thomas D, Zhao L, Brown N, Frankel TL, Warren EH, Ramnath N. Qin A, et al. Int J Radiat Oncol Biol Phys. 2020 Sep 1;108(1):170-177. doi: 10.1016/j.ijrobp.2019.10.047. Epub 2019 Nov 19. Int J Radiat Oncol Biol Phys. 2020. PMID: 31756415

2

Mechanisms of immune evasion and current status of checkpoint inhibitors in non-small cell lung cancer.

Qin A, Coffey DG, Warren EH, Ramnath N. Qin A, et al. Cancer Med. 2016 Sep;5(9):2567-78. doi: 10.1002/cam4.819. Epub 2016 Jul 15. Cancer Med. 2016. PMID: 27416962 Free PMC article. Review.

3

Clinical Determinants of Durable Clinical Benefit of Pembrolizumab in Veterans With Advanced Non-Small-Cell Lung Cancer.

Qin A, Street L, Cease K, Viglianti BL, Warren EH, Zhao L, Ramnath N. Qin A, et al. Clin Lung Cancer. 2017 Sep;18(5):559-564. doi: 10.1016/j.cllc.2017.01.012. Epub 2017 Feb 9. Clin Lung Cancer. 2017. PMID: 28366756 Free PMC article. Clinical Trial.

4

Cisplatin, Etoposide, and Irinotecan for Relapsed Small-Cell Lung Cancer.

Qin A, Kalemkerian GP. Qin A, et al. Transl Cancer Res. 2016 Nov;5(Suppl 6):S1142-S1144. doi: 10.21037/tcr.2016.11.22. Transl Cancer Res. 2016. PMID: 28523239 Free PMC article. No abstract available.

5

The "liquid biopsy" in non-small cell lung cancer - not quite ready for prime time use.

Qin A, Ramnath N. Qin A, et al. Transl Cancer Res. 2016 Oct;5(Suppl 4):S632-S635. doi: 10.21037/tcr.2016.10.29. Transl Cancer Res. 2016. PMID: 28983463 Free PMC article. No abstract available.

6

Is Prophylactic Cranial Irradiation the Standard of Care for Extensive-Stage Small-Cell Lung Cancer?

Qin A, Kalemkerian GP. Qin A, et al. J Oncol Pract. 2017 Nov;13(11):739-740. doi: 10.1200/JOP.2017.027631. J Oncol Pract. 2017. PMID: 29125922 No abstract available.

7

Treatment Options for Relapsed Small-Cell Lung Cancer: What Progress Have We Made?

Qin A, Kalemkerian GP. Qin A, et al. J Oncol Pract. 2018 Jun;14(6):369-370. doi: 10.1200/JOP.18.00278. J Oncol Pract. 2018. PMID: 29894661 No abstract available.

8

Use of Bone-Modifying Agents in Myeloma and Bone Metastases: How Recent Dosing Interval Studies Have Affected Our Practice.

Campagnaro E, Reimers MA, Qin A, Alva AS, Schneider BJ, Van Poznak CH. Campagnaro E, et al. Among authors: qin a. J Oncol Pract. 2018 Aug;14(8):457-464. doi: 10.1200/JOP.18.00236. J Oncol Pract. 2018. PMID: 30096277 Review.

9

PD-L1 Expression in Circulating Tumor Cells Increases during Radio(chemo)therapy and Indicates Poor Prognosis in Non-small Cell Lung Cancer.

Wang Y, Kim TH, Fouladdel S, Zhang Z, Soni P, Qin A, Zhao L, Azizi E, Lawrence TS, Ramnath N, Cuneo KC, Nagrath S. Wang Y, et al. Among authors: qin a. Sci Rep. 2019 Jan 24;9(1):566. doi: 10.1038/s41598-018-36096-7. Sci Rep. 2019. PMID: 30679441 Free PMC article.

10

Chemotherapy and Radiation Versus Chemotherapy Alone for Elderly Patients With N3 Stage IIIB NSCLC.

Qin A, Lusk E, Daignault-Newton S, Schneider BJ. Qin A, et al. Clin Lung Cancer. 2019 Jul;20(4):e495-e503. doi: 10.1016/j.cllc.2019.04.003. Epub 2019 Apr 19. Clin Lung Cancer. 2019. PMID: 31088760 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,032 results

Search Page